| Financial Year |
March 31 2023 |
| Monetary Funds |
1,414,324,425.89 |
| Held-for-trading Financial Assets |
503,852,685.25 |
| Notes Receivable |
22,602,812.51 |
| Accounts Receivable |
667,160,671.22 |
| Advances to Suppliers |
17,370,926.45 |
| Other Receivables |
9,030,303.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,031,074,998.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
97,691,793.97 |
| Other Current Assets |
59,175,046.85 |
| Total Current Assets |
4,246,944,771.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,615,612.84 |
| Investment Properties |
8,848,660.55 |
| Fixed Assetes |
938,517,578.69 |
| Under-construction Projects |
108,275,273.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
120,885,006.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,979,507.94 |
| Deferred Income Tax Assets |
59,701,255.52 |
| Other Non-Current Assets |
112,950,423.33 |
| Sub-Total of Non-Current Assets |
1,505,454,482.93 |
| Total Assets |
5,752,399,254.61 |
| Short-Term Loans |
805,938,002.00 |
| Trading Financial liabilities |
244,368.09 |
| Notes Payable |
331,505,922.10 |
| Accounts Payable |
676,755,515.59 |
| Accounts Received In Advance |
473,424.69 |
| Employee Compensation Payable |
80,554,978.37 |
| Taxes Payable |
77,710,412.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,130,466.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,703,201.74 |
| Other Current Liabilities |
24,837,838.73 |
| Sub-Total of Current Liabilities |
2,267,650,544.21 |
| Long-term Loans |
196,386,529.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,519,004.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
298,197,220.51 |
| Total Liabilities |
2,565,847,764.72 |
| Paid-In Capital(Or Share Stock) |
534,724,139.00 |
| Capital Surplus |
442,703,478.77 |
| Surplus Reserve |
285,238,189.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,901,935,286.79 |
| Minority Stockholder's Interest |
18,780,904.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,167,770,585.15 |
| Owner's Equity（Stockholder's Equity） |
3,186,551,489.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,752,399,254.61 |
